These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2425059)

  • 1. Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
    Messerli FH
    J Clin Hypertens; 1985 Mar; 1(1):3-14. PubMed ID: 2425059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular pathophysiology of essential hypertension: a clue to therapy.
    Messerli FH; Ventura HO
    Drugs; 1985; 30 Suppl 1():25-34. PubMed ID: 2994985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential hypertension. Matching pathophysiology and pharmacology.
    Messerli FH
    Postgrad Med; 1987 Feb; 81(2):165-72, 179-80. PubMed ID: 3543906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of diuretic agents in obese or black patients with systemic hypertension.
    Messerli FH; Schmieder RE
    Am J Cardiol; 1986 Jul; 58(2):11A-14A. PubMed ID: 3728340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension.
    Stott D; Papastefanou I; Paraschiv D; Clark K; Kametas NA
    Ultrasound Obstet Gynecol; 2017 Jan; 49(1):95-103. PubMed ID: 27800645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach.
    Messerli FH
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S875-9. PubMed ID: 6084143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
    Moser M; Frishman W
    Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of coronary artery disease in patients with hypertensive left ventricular hypertrophy.
    Dunn FG
    Am J Med; 1983 Sep; 75(3A):75-9. PubMed ID: 6137949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of systemic hypertension in blacks.
    Weir MR; Saunders E
    Am J Cardiol; 1988 Jun; 61(16):46H-52H. PubMed ID: 3289351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.